Prognostic value of deep learning-derived body composition in advanced pancreatic cancer—a retrospective multicenter study
Authors:
- J. KeylJKJ. Keyl
- T.M. ReissigTRT.M. Reissig
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Deutschen Konsortium für Translationale Krebsforschung (405344257/SI 1549/3-2)
This publication has 33 references indexed in Scilit:
- Cancer-associated cachexiaNature Reviews Disease Primers, 2018
- Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based ChemotherapyCancer Research and Treatment, 2016
- The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinomaClinical Nutrition, 2016
- Muscle Quality and Myosteatosis: Novel Associations With Mortality RiskAmerican Journal of Epidemiology, 2015
- Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass IndexPLOS ONE, 2015
- Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopeniaProceedings of the Nutrition Society, 2015
- Intermuscular Fat: A Review of the Consequences and CausesInternational Journal of Endocrinology, 2014
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexJournal of Clinical Oncology, 2013
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic CancerClinical Cancer Research, 2009
- Matplotlib: A 2D Graphics EnvironmentComputing in Science & Engineering, 2007